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ABSTRACT
Background. Oxytetracycline (OTC), which is largely employed in zootechnical
and veterinary practices to ensure wellness of farmed animals, is partially absorbed
within the gastrointestinal tract depositing in several tissues. Therefore, the potential
OTC toxicity is relevant when considering the putative risk derived by the entry and
accumulation of such drug in human and pet food chain supply. Despite scientific
literature highlights several OTC-dependent toxic effects on human and animal health,
the molecular mechanisms of such toxicity are still poorly understood.
Methods. Here, we evaluated DNA damages and epigenetic alterations by quantitative
reverse transcription polymerase chain reaction, quantitative polymerase chain reac-
tion, chromatin immuno-precipitation and Western blot analysis.
Results. We observed that human peripheral blood mononuclear cells (PBMCs)
expressedDNAdamage features (activation of ATMandp53, phosphorylation ofH2AX
and modifications of histone H3 methylation of lysine K4 in the chromatin) after the
in vitro exposure to OTC. These changes are linked to a robust inflammatory response
indicated by an increased expression of Interferon (IFN)-γ and type 1 superoxide
dismutase (SOD1).
Discussion. Our data reveal an unexpected biological in vitro activity of OTC able to
modify DNA and chromatin in cultured human PBMC. In this regard, OTC presence in
foods of animal origin could represent a potential risk for both the human and animal
health.
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INTRODUCTION
The drug (4S,4aR,5S,5aR, 6S,12aS)-4-(dimethylamino)-3,5,6,10,12,12a-hexahydroxy-
6-methyl-1,11-dioxo1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide, briefly
oxytetracycline (OTC) is active towards a wide range of micro-organisms (Nelson &
Levy, 2011), is efficiently absorbed in the duodenum forming complexes with metallic ions,
is unstable at acid pH and its introduction along with food reduces its serum concentrations
(Palmieri, Di Cerbo & Laurino, 2014). Moreover, such drug could accumulate within bone,
skin, fat, tendons, muscles, liver and gastrointestinal tract (Agwuh & MacGowan, 2006).
OTC is commonly used in medicine and is one of the main antibiotics used in zootech-
nical and veterinary practices as feed supplement to ensure wellness of farmed animals
(i.e., poultry, ovine, swine and livestock) (Graham et al., 2014;Brüning et al., 2014;Di Cerbo
et al., 2014; Odore et al., 2015).
Several studies have investigated the potential toxicity of OTC ranging from teratogenic
effects during pregnancy (Czeizel & Rockenbauer, 2000) to some effect on immune system
(Glette et al., 1984; Potts et al., 1983; Van den Bogert & Kroon, 1982; Myers, Farrell & Hen-
derson, 1995; Di Cerbo et al., 2016). Moreover, scientific literature suggested that the drug
is able to inhibit or reduce catalase (Chi, Liu & Zhang, 2010) and affects avian cartilage
degradation (Peters et al., 2002).
We recently demonstrated that OTC: (a) induces an in vitro inflammatory response
characterized by T and non-T lymphocytes activation and Interferon (IFN)-γ release
(Di Cerbo et al., 2016); (b) triggers the apoptosis of human and dog haematopoietic cells
(Di Cerbo et al., 2016; Odore et al., 2015).
The potential OTC toxicity becomes more relevant when considering the potential risk
derived by the eventuality of entry and accumulation of such drug in human and pet food
with possible consequences on health (Palmieri, Di Cerbo & Laurino, 2014). In this regard,
animal muscle, bone and fat are known to be the elective deposit for several antibiotics
(Palmieri, Di Cerbo & Laurino, 2014; Macy & Poon, 2009) and are routinely employed for
human and pet food production (Palmieri, Di Cerbo & Laurino, 2014).
In the light of the widespread use of OTC and considering the putative risk derived
by the eventuality of entry and accumulation of such drug in human and pet food chain
supply (Graham et al., 2014; Brüning et al., 2014;Di Cerbo et al., 2014;Nelson & Levy, 2011;
Palmieri, Di Cerbo & Laurino, 2014), it is possible to speculate that the OTC accumulates
in these edible tissues and that this occurrence represents the contact between the drug and
the humans or companion animals (dogs and cats).
Here, we addressed the study over the relevance of some molecular mechanisms of drug
toxicity and, specifically, on the genotoxic effect and epigenetic modifications potentially
induced by OTC. This could be relevant since many of the effects observed could affect the
gene expression and represent a potential risk for human and animal health.
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MATERIALS & METHODS
Cells and incubation
Peripheral blood mononuclear cells (PBMCs) were obtained, as previously described (Di
Cerbo et al., 2016). Briefly, we performed the centrifugation on Ficoll-Paque cushion (GE
Healthcare, Uppsala Sweden) gradients of buffy coats obtained from six volunteer healthy
donors. In order to inform the blood donors concerning the possibility to use minimal
amount of their blood donation for scientific purpose, written informed consent (model
n. 5526 of Azienda Ospedaliera Universitaria ‘‘FEDERICO II’’, Naples, Italy) was obtained
from each donor at the time of venous peripheral blood donation performed at Blood
Trasfusional Center of Azienda Ospedaliera Universitaria ‘‘FEDERICO II’’, Naples Italy, as
established by Italian Law. All the experiments were performed anonymously, without any
donor biographical reference. White blood cells have never been used to create a genome
database.
To test the in vitro potential biochemical toxic role of OTC (Liquid Oxytetracycline 20%
R, TreI, Reggio Emilia, Italy), the PBMCs (2.5 × 106/ml) were incubated in presence of
RPMI 1,640mediumwith 10% FCS (Invitrogen, Carlsbad, CA, USA) alone or with 2 µg/ml
OTC (Odore et al., 2015; Di Cerbo et al., 2016) at 37 ◦C for different times (6 h, 12 h, 24 h).
RNA extraction and qRT-PCR and qPCR
Total RNA was extracted using TRI Reagent (T9424, Sigma-Aldrich, St Louis, MO,
USA). cDNA was synthesized in a 20 µl reaction volume containing 1 µg of total RNA, in
accordance to the life technology protocol (High-Capacity cDNAReverse Transcription Kit
4368814; Applied Biosystem, Thermofisher Scientific, Foster City, CA, USA). The products
were stored at −20 ◦C until use. Quantitative reverse transcription polymerase chain
reaction (qRT-PCR) and quantitative polymerase chain reaction (qPCR) were performed
three times in six replicates on a 7,500 Real Time PCR System (Applied Biosystems) using
the SYBR Green-detection system (SYBR select Master Mix, 4473369, Applied Biosystem).
The following primers were used: IFN-γ mRNA, 5′-TGGAAAGAGGAGAGTGACAGA-3′
and 5′-CTGTTTTAGCTGCTGGCGAC-3′; type 1 superoxide dismutase (SOD1) mRNA
5′-CTAGCGAGTTATGGCGACGA-3′ and 5′-GTCTCCAACATGCCTCTCTTCA-3′; 18S,
5′-GCGCTACACTGACTGGCTC-3′ and 5′-CATCCAATCGGTAGTAGCGAC-3′.
Chromatin Immuno-Precipitation (ChIP)
Cells were treated as indicated in Cells and incubation paragraph. The cells (∼2.5× 106 for
each antibody) were crosslinked with a 1% formaldeyhyde/PBS solution for 10min at room
temperature, the reaction was stopped by the addition of glycine to a final concentration
of 125 mM. Fixed cells were harvested and the pellet was resuspended in 1 ml of Lysis
Buffer (10 mM Tris-HCl pH 8.0, 10 mM NaCl, 0.2% NP40) containing 1× protease
inhibitor cocktail (Roche Applied Science, Basel, Switzerland). The lysates were sonicated
in order to have DNA fragments from 300 to 600 bp. An aliquot (1/10) of sheared
chromatin was used as input DNA. Sonicated samples were processed according to
the manufacturer’s protocol of ChIP assay kit (Merck Millipore, Billerica, MA, USA).
Samples were subjected to qPCR using the following primers: IFN-γ Promoter, 5′-GAA
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CAATGTGCTGCACCTCC-3′ and 5′-CACAGGTGGGCATAATGGGT-3′; SOD1 Pro-
moter, 5′-CATCATTTTGCCAATTTCGCGT-3′ and 5′-CGAGTGGCCGGGAATGACT-3′.
Real Time-qPCRs were performed using the SYBR Green-detection system (SYBR select
Master Mix, 4473369; Applied Biosystem).
Western blot preparation and analysis
Aliquots of the cells collected for ChIP were used for western blot. Cells were washed
twice with cold phosphate-buffered saline (PBS) and nuclei were extracted using 1 ml of
Lysis Buffer (10 mM Tris-HCl pH 8.0, 10 mM NaCl, 0.2% NP40) containing 1× protease
inhibitor cocktail. Nuclear lysates were obtained accordingly with Nuclear Fractionation
Protocol (Abcam, Cambridge, UK). γH2AX was detected using part of the sonicated
samples collected for ChIP. Lysates were cleared by centrifugation (13,000 rpm for 20 min).
Protein concentrations were measured by Bio-Rad Protein Assay Dye Reagent Concentrate
#500-0006. Equal amounts of cell extracts were then resolved by SDS–PAGE, transferred
to nitrocellulose membranes, and immunoblotted using specific antibodies. Blots were
detected using an ECL system (LumilightWestern Blotting Substrate, 12015200001, Roche).
Antibodies
Anti-DNMT1 ab87656 (Abcam, Cambridge, UK), -H3K4me2 ab32356 (Abcam), -
H3K4me3 ab1012 (Abcam),—Total H3 ab1791 (Abcam), -Menin sc-0200 (Santa Cruz
Biotechnology); phosphoATM ab81292 (Abcam), -phospho-H2AX (07164, Merck Milli-
pore), MCM7 sc-9966 (Santa Cruz Biotechnology), Normal rabbit IgG sc-2027 (Santa Cruz
Biotechnology), Normal mouse IgG sc-2025 (Santa Cruz Biotechnology) and -p53 ab1101
(Abcam).
Statistical analysis
Statistical significance between groups was determined using Student’s t test.
RESULTS AND DISCUSSION
IFN-γ and SOD1 gene expression
We recently demonstrated the pro-inflammatory effect of OTC in causing both the IFN-γ
secretion in T and non-T lymphocytes (Di Cerbo et al., 2016). Here, we evaluated the effect
of drug treatment in the up-regulation of IFN-γ gene expression. Figure 1A shows that
mRNA levels of IFN-γ robustly increased in PBMCs after 24 h of OTC incubation.
To investigate if OTC-mediated inflammatory condition could depend on oxidative
stress, we evaluated whether the Cu–Zn Super Oxide Dismutase 1 (SOD1) could be
increased after drug exposure. It is of note that one of the SOD1 is involvednot only in oxida-
tive metabolism but also in the T lymphocyte activation dependent on the accumulation of
reactive oxygen species (Terrazzano et al., 2014). Our data (Fig. 1B) show that the mRNA
levels of SOD1 increased from 12 to 24 h of OTC treatment.
The data reported in Fig. 1 showed that the enhancement of mRNA levels of IFN-γ
occurred after 24 h of OTC-treatment, whereas the induction of SOD1 mRNA appeared
already in 12 h. A possible explanation might be that SOD1 is a housekeeping gene (Minc et
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Figure 1 OTC induces IFN-γ and SOD1mRNA. OTC significantly induces the increment of both IFN-
γ and SOD1 mRNA. Total RNA was prepared from PBMC stimulated with OTC for 6, 12, 24 h, as indi-
cated in ‘Materials & Methods’, and analyzed by qPCR with specific primers to IFN-γ (A) and SOD1 (B)
mRNA normalized to 18S RNA levels. The statistical analysis derived from 2 experiments in triplicate (n≥
6; Mean± SD).
al., 1999) and its basal expression is usually higher than IFN-γ gene. Since the used in vitro
model is based on freshly isolated PBMCs that are usually resistant to natural occurring
apoptosis (Miyawaki et al., 1992), the increased SOD1 level after the drug incubation could
be likely associated to the hypothesis of apoptosis induction upon chromatin and DNA
damages (Norbury & Zhivotovsky, 2004; Barbosa et al., 2010).
These results suggest that the drug may affect some important cellular responses as the
induction of a gene expression fostering the activation of previously observed immune
response by T and non-T lymphocytes after in vitro OTC exposure (Di Cerbo et al., 2016).
OTC generates genotoxic damage
Since the OTC is able to induce apoptosis (Odore et al., 2015; Di Cerbo et al., 2016), we
investigated on the potential ability of such drug in causing DNA damage and, in reason of
that, in inducing apoptosis. In particular, we evaluated the presence of genotoxic markers
after in vitro drug treatment of PBMCs. In this regard, it is worth noting the role for Ataxia
Telangiectasia mutated protein (ATM) that is a serin/treonin kinase activated in response
to the DNA double strand break to promote cell cycle arrest, DNA repair and, if necessary,
the cell death by apoptosis (Canman & Lim, 1998; Lee & Paull, 2007).
As shown in Fig. 2A, the phosphorylated form of ATM (pATM) is clearly increased in
human PBMCs after 6 h and 12 h of OTC incubation.
Furthermore, we investigated the levels of p53, as one of principal substrates of pATM
and an important marker of DNA damage (Sakaguchi et al., 1998;Williams & Schumacher,
2016). Figure 2A indicates that p53 significantly increased after 12 h of drug exposure.
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Figure 2 OTC induces genotoxic damage. Cells were treated with OTC for 6, 12 and 24 h and processed
as indicated in ‘Material and Methods’. (A) the western blot for pATM, p53 and DNMT1 was performed
using nuclear extract. Menin is reported as loading control; (B) quantification of the western blots nor-
malized to Menin levels. Values are reported as Optical density (arbitrary units= a.u.).
These observations suggest that some DNA damage may occur after OTC incubation.
One of the main epigenetic modifications involved in gene regulation is the DNA
methylation (Hamidi, Singh & Chen, 2015). It is well known that DNA (cytosine-5)-
methyltransferase 1 enzyme (DNMT1) is recruited to the chromatin, in response to the
oxidative DNA damage, in order to inhibit gene transcription and to support DNA repair
(Ding et al., 2016). It is of relevance that DNMT1 appears to increase after OTC treatment,
following a similar kinetics of pATM and p53 (Fig. 2A).
Such evidence supports the idea that the enzymes could be recruited on the site of
oxidativeDNAdamage occurred uponOTC incubation and cooperate each-other to induce
chromatin modifications aimed to foster the DNA repair (Morano et al., 2014).
To better address the entity of DNA damage, we investigated the presence of DNA
double strand break (DBS) markers. In particular, we evaluated the phosphorylated histone
H2AX (γH2AX) (Rogakou et al., 1998; Mah, El-Osta & Karagiannis, 2010) by performing
western blot analysis on chromatin samples. Figures 3A and 3B shows the significant
increase of γH2AX with the highest peak from 12 to 24 h of drug treatment. Notably, the
phosphorylated histone H2AX binds the regions of chromatin on the sites of DSB and
DNA repair (Mah, El-Osta & Karagiannis, 2010). To better analyze the chromatin changes
caused by the drug, we tested by ChIP assay the presence of γH2AX on the promoters of
genes of our interest. We observed the accumulation of γH2AX at the site of promoter
of IFN-γ gene (Fig. 3C). The presence of γH2AX was also enhanced at the level of SOD1
gene promoter after 24 h of drug incubation (Fig. 3D).
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Figure 3 OTC and the chromatin changes. (A) The western blot for γH2AX performed on chromatin
extracts. MCM7 is reported as loading control; (B) Quantification of γH2AX normalized to MCM7 levels.
Values are reported as Optical density (arbitrary units= a.u.); qChIP analysis evideces that γH2AX accu-
mulates on IFN-γ (C) and SOD1 (D) promoters. Cells were treated with OTC as indicated, crosslinked
and sonicated. The statistical analysis derived from at least 2 experiments in triplicate (n≥ 6; Mean± SD).
Therefore, our results strongly suggest the correlation between DNA damage occurrence
and OTC administration. Moreover, the increased levels of IFN-γ and SOD1 mRNAs
(Fig. 1) appear to be linked to the function of γH2AX, which cooperates with the induction
of ATM mediated transcription (Singh et al., 2015).
Epigenetic changes
Histone modification represents an epigenetic mechanism that affects gene transcription
by altering the chromatin structure and DNA accessibility. Histone methylation can be
associated with the different status of chromatin (Zhang, Cooper & Brockdorff, 2015). Here,
we evaluated if OTC treatment could be correlated to alterations of histone methylation.
More specifically, we investigated on the methylation status of lysine 4 of Histone 3 (H3K4)
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Figure 4 OTC and histone methylation.Methylation profile of histone H3K4 is induced by OTC on
both the IFN-γ and SOD1 gene promoters. PMBC cells were exposed to OTC at the indicated times (0, 6,
12 and 24 h). qChIP was carried out using specific antibodies; (A) H3K4me3 and H3K4me2 occupancy at
IFN-g promoter; (B): H3K4me2 and H3K4me3 occupancy at SOD1 promoter; (C) and (D); the TotalH3
occupancy at IFN-γ and SOD1 promoters respectively. The statistical analysis derived from at least 2 ex-
periments in triplicate (n≥ 6; Mean± SD).
that is implicated in the regulation of gene activation (Barski et al., 2007; Ruthenburg, Allis
& Wysocka, 2007).
To this aim, we performed a ChIP for the promoter of the genes whose expression
appeared to be modified by OTC. After 24 h of drug incubation, the increment of both
the di-methylated (me2) and tri-methylated (me3) H3K4 is particularly evident for IFN-γ
promoter (Fig. 4A), while the increase of H3K4 is more evident for the di-methylated
form at the level of SOD1 promoter (Fig. 4B). These data are correlated with the observed
activation of gene expression (Bernstein et al., 2005). Similar results are obtained from the
analysis of total H3 histone levels (Figs. 4C and 4D).
Together, these data indicate that the OTC treatment can affect the status of
chromatin.
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CONCLUSION
Despite scientific literature that has been suggesting the potential toxicity of OTC (Czeizel
& Rockenbauer, 2000; Glette et al., 1984; Potts et al., 1983; Van den Bogert & Kroon, 1982;
Myers, Farrell & Henderson, 1995), the mechanisms of the toxic effect of such drug is still
poor understood.
We recently demonstrated that OTC induces in vitro inflammatory response (Di Cerbo
et al., 2016) and apoptosis (Di Cerbo et al., 2016; Odore et al., 2015). Therefore, this and
other suggestions open an interesting scenario on the toxicity of OTC that requires a greater
understanding over the nature of observed toxic effects.
This study emphasized the toxicity of OTC, investigating over themolecularmechanisms
involved in human PBMC inflammatory response. It is of note that the drug promoted a ro-
bust inflammatory response as represented by the increasing of IFN-γ mRNA levels. This re-
sult reflects and confirms the previously observed increment of IFN-γ production in T and
non-T lymphocytes (Di Cerbo et al., 2016). In addition, OTC significantly induced SOD1
mRNA in the same experimental condition and cellular model. This evidence extends our
previous observations on apoptosis induction after OTC exposure (Terrazzano et al., 2014;
Odore et al., 2015).
In addition,we observed thatOTC induces genotoxic damage aswell as such drug recruits
some enzymes implicated in the delicate balance between cell death and survival. Indeed,
our data evidenced the increased levels of pATM, p53 and DNMT1 after drug incubation.
It is of note that p53 is a substrate of pATM and is crucial to the cell cycle arrest and/or
to induce the cell death by apoptosis (Norbury & Zhivotovsky, 2004), while DNMT1 repre-
sents a specific enzyme involved in some epigenetic changes (Hamidi, Singh & Chen, 2015),
associated with the DNA damage (Rossetto et al., 2010).
Moreover, we observed the activation of γH2AX, as a main DSB sensor protein, and
suggested an epigenetic effect of OTC on the methylation status of H3K4 that is implicated
in gene expression regulation (Barski et al., 2007; Ruthenburg, Allis & Wysocka, 2007). The
increase of both me2 and me3 H3K4 occurred after OTC incubation and was evident for
IFN-γ and SOD1 gene promoters.
Our data represent a preliminary step in the understanding of OTC toxicity, since
the knowledge of the molecular mechanisms involved in the toxic effect may help in the
generation of new drugs with reduced risk for human health.
In conclusion, it could be of great relevance to ascertain the possible acute and long term
effects of OTC on human health. It is worth noting that the use of antibiotics for growth
promotion is prohibited in Europe and it is considered a health hazard byWHO since 2006.
The use of antibiotics in agriculture for non-therapeutic purposes is allowed in United
States and Canada (FaAOF, 2014). Therefore, new regulations are urgently necessary to
reduce antibiotic contaminants in foods as well as the antibiotic resistance phenomenon
(US Government Publishing Office, 2014).
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STUDY LIMITATIONS
Notably, the current study incurs some limitations that are not addressable without
further researches. In this regard, our study did not perform chemical-pharmaceutical
and pharmacological test to evaluate the molecular complexity and/or stability of the used
OTC or to verify the possible presence of active sub-products generated during in vitro
tests. In addition, this study did not address any chemical evaluation of the excipients (i.e.,
fillers, binders, dyes, flavorings, preservatives and other materials) present in the here used
commercial liquid formulation of OTC drug employed in veterinary medicine. Therefore,
further evaluations are required to complete the significance of OTC toxicity. In particular,
the absence of in vivo experiments, able to confirm the in vitro observed OTC toxicity,
represents the main relevant limitation. Therefore, clinical studies are required to ascertain
the effect of the drug in inducing the inflammatory status in animals and/or in humans.
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